BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36675827)

  • 1. The Comparative Evaluation of the Fujifilm Wako β-Glucan Assay and Fungitell Assay for Diagnosing Invasive Fungal Disease.
    Singh S; Kanaujia R; Agnihotri S; Kaur H; Chakrabarti A; Rudramurthy SM
    J Fungi (Basel); 2022 Dec; 9(1):. PubMed ID: 36675827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-d-Glucan for Diagnosing
    Mercier T; Guldentops E; Patteet S; Beuselinck K; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
    De Carolis E; Marchionni F; Torelli R; Angela MG; Pagano L; Murri R; De Pascale G; De Angelis G; Sanguinetti M; Posteraro B
    PLoS One; 2020; 15(7):e0236095. PubMed ID: 32726358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
    Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
    Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wako β-D-glucan assay can be used to measure serum β-D-glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis.
    Nyuykonge B; Siddig E; Mhmoud NA; Bakhiet S; Zijlstra E; Verbon A; Fahal AH; van de Sande WWJ
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):783-786. PubMed ID: 36201367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
    Friedrich R; Rappold E; Bogdan C; Held J
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
    White SK; Schmidt RL; Walker BS; Hanson KE
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective comparison of (1,3)-beta-D-glucan detection using colorimetric and turbidimetric assays for diagnosing invasive fungal disease.
    Alanio A; Gits-Muselli M; Guigue N; Denis B; Bergeron A; Touratier S; Hamane S; Bretagne S
    Med Mycol; 2021 Sep; 59(9):882-889. PubMed ID: 33877326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
    He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
    J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
    Bamba Y; Nagano K; Moro H; Ogata H; Hakamata M; Shibata S; Koizumi T; Aoki N; Ohshima Y; Watanabe S; Nakamura T; Kobayashi S; Hoshiyama Y; Koya T; Takada T; Kikuchi T
    PLoS One; 2021; 16(8):e0255172. PubMed ID: 34437556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Turbidimetric β-d-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia.
    Dichtl K; Seybold U; Wagener J
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29720434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
    Kritikos A; Caruana G; Poissy J; Mamin A; Bachmann D; Pagani JL; Coste AT; Lamoth F
    J Clin Microbiol; 2023 Feb; 61(2):e0169122. PubMed ID: 36700626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
    Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-D-Glucan Assay in Diagnosis and Monitoring the Systemic Candidiasis in a Rat Model.
    Khodadadi H; Mirhendi H; Makimura K; Satoh K; Karimi L; Izadi S
    Jundishapur J Microbiol; 2014 Jun; 7(6):e10247. PubMed ID: 25371794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two β-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
    Song J; Kim S; Park J; Park Y; Kim HS
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115415. PubMed ID: 34082306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
    Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
    Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of Fungitell STAT™, a rapid (1→3)-β-D-glucan single patient sample in vitro diagnostic assay.
    D'Ordine RL; Garcia KA; Roy J; Zhang Y; Markley B; Finkelman MA
    Med Mycol; 2021 Jan; 59(1):41-49. PubMed ID: 32400855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan.
    Yoshida K; Shoji H; Takuma T; Niki Y
    J Infect Chemother; 2011 Aug; 17(4):473-7. PubMed ID: 21210174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.